InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the full record of transactions filed by Klee Justin B., Chairman & CEO. Insider active across 1 companies, notably Amylyx Pharmaceuticals, Inc.. Aggregated, 3 reports have been logged. The latest transaction was disclosed on 5 May 2022 (Levée d'options). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations3 total
€117,434334,520 shares@ €0.35110.0080% mcap100.0% of flow
Common Stock
SEC:0000899243-22-017084:0·
04,870 shares0
Common Stock
SEC:0000899243-22-001511·
04,870 shares0
Common Stock
SEC:0000899243-22-001511:0·
3 of 3 declarations
About Klee Justin B.
Justin B. Klee is Co-Chief Executive Officer at Amylyx Pharmaceuticals, Inc. In this role, he leads the company's operations and strategy in the pharmaceutical sector. His expertise in this field allows him to drive innovative initiatives to improve treatments offered to patients.
